Literature DB >> 10848990

Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1.

D Meredith1, C S Temple, N Guha, C J Sword, C A Boyd, I D Collier, K M Morgan, P D Bailey.   

Abstract

The binding affinities of a number of amino-acid and peptide derivatives by the mammalian intestinal peptide transporter PepT1 were investigated, using the Xenopus laevis expression system. A series of blocked amino acids, namely N-acetyl-Phe (Ac-Phe), phe-amide (Phe-NH2), N-acetyl-Phe-amide (Ac-Phe-NH2) and the parent compound Phe, was compared for efficacy in inhibiting the uptake of the peptide [3H]-D-Phe-L-Gln. In an equivalent set of experiments, the blocked peptides Ac-Phe-Tyr, Phe-Tyr-NH2 and Ac-Phe-Tyr-NH2 were compared with the parent compound Phe-Tyr. Comparing amino acids and derivatives, only Ac-Phe was an effective inhibitor of peptide uptake (Ki = 1.81+/- 0.37 mM). Ac-Phe-NH2 had a very weak interaction with PepT1 (Ki = 16.8+/-5.64 mM); neither Phe nor Phe-NH2 interacted with PepT1 with measurable affinity. With the dipeptide and derivatives, unsurprisingly the highest affinity interaction was with Phe-Tyr (Ki = 0.10+/-0.04 mM). The blocked C-terminal peptide Phe-Tyr-NH2 also interacted with PepT1 with a relatively high affinity (Ki = 0.94+/-0.38 mM). Both Ac-Phe-Tyr and Ac-Phe-Tyr-NH2 interacted weakly with PepT1 (Ki = 8.41+/-0.11 and 9.97+/-4.01 mM, respectively). The results suggest that the N-terminus is the primary binding site for both dipeptides and tripeptides. Additional experiments with four stereoisomers of Ala-Ala-Ala support this conclusion, and lead us to propose that a histidine residue is involved in binding the C-terminus of dipeptides. In addition, a substrate binding model for PepT1 is proposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848990     DOI: 10.1046/j.1432-1327.2000.01405.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  23 in total

Review 1.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

3.  Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line.

Authors:  Carsten Uhd Nielsen; Claudiu T Supuran; Andrea Scozzafava; Sven Frokjaer; Bente Steffansen; Birger Brodin
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

4.  A POTluck of peptide transporters.

Authors:  Poul Nissen
Journal:  EMBO J       Date:  2012-07-27       Impact factor: 11.598

5.  Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro study.

Authors:  Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal:  Pharm Res       Date:  2011-06-14       Impact factor: 4.200

Review 6.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

Authors:  Anand Balakrishnan; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

7.  The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.

Authors:  Yasuhiro Tsume; Tuba Incecayir; Xueqin Song; John M Hilfinger; Gordon L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2013-12-19       Impact factor: 5.571

8.  Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.

Authors:  Tomomi Uchiyama; Ashutosh A Kulkarni; Daryl L Davies; Vincent H L Lee
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

9.  Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.

Authors:  Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal:  Mol Pharm       Date:  2008-07-25       Impact factor: 4.939

10.  Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1.

Authors:  David Foley; Patrick Bailey; Myrtani Pieri; David Meredith
Journal:  Org Biomol Chem       Date:  2009-01-21       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.